fe3o4 astragalus polysaccharide core shell nanoparticles for iron deficiency anemia therapy and magnetic resonance imaging in vivo
Male
Cell Survival
Contrast Media
FOS: Physical sciences
02 engineering and technology
Kidney
Cell Line
Mice
Drug Stability
Polysaccharides
Animals
Humans
Physics - Biological Physics
Rats, Wistar
Mice, Inbred ICR
Anemia, Iron-Deficiency
Astragalus Plant
Physics - Medical Physics
Magnetic Resonance Imaging
Ferrosoferric Oxide
Rats
3. Good health
Liver
Solubility
Biological Physics (physics.bio-ph)
Nanoparticles
Medical Physics (physics.med-ph)
0210 nano-technology
DOI:
10.48550/arxiv.1806.10740
Publication Date:
2019-02-25
AUTHORS (10)
ABSTRACT
Fe3O4@astragalus polysaccharide core-shell nanoparticles (Fe3O4@APS NPs) were demonstrated to be an efficient therapeutic drug for treating iron deficiency anemia (IDA) in vivo. The Fe3O4@APS NPs have been synthesized using a two steps approach involving hydrothermal synthesis and subsequent esterification. Transmission electron microscopy (TEM) and Fourier transform infrared (FTIR) spectroscopy studies show that APS are attached on the surfaces of the highly monodisperse Fe3O4 NPs. Dynamic light scatting (DLS) and magnetic characterizations reveal that the Fe3O4@APS NPs have outstanding water solubility and stability. Cytotoxicity assessment using Hela cells and pathological tests in mice demonstrate their good biocompatibility and low toxicity. The IDA treatment in rats shows that they have efficient therapeutic effect, which is contributed to both the iron element supplement from Fe3O4 and the APS-stimulated hematopoietic cell generation. Moreover, the Fe3O4@APS NPs are superparamagnetic and thus able to be used for magnetic resonance imaging (MRI). This study has demonstrated the potential of nanocomposites involving purified natural products from Chinese herb medicine for biomedical applications.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES ()
CITATIONS ()
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....